Arthritis Drugs In the Medical Literature This Month
October 31, 2005
| Cardiovascular Safety of Lumiracoxib: A Meta-Analysis of All Randomized Controlled Trials >/=1 Week and Up to 1 Year in Duration of Patients with Osteoarthritis and Rheumatoid Arthritis |
Journal: Clinical Therapeutics 2005 Aug;27(8):1196-214
Authors: P. Matchaba, X. Gitton, G. Krammer, E. Ehrsam, V.S. Sloan, M. Olson, B. Mellein, G. Hoexter, J. Orloff, J.J. Garaud
Summary: The study aimed to determine the risk of cardiovascular events associated with the COX-2 drug Prexige based on a meta-analysis of all completed, randomized controlled trials of more than or equal to one year and up to one …
UPCOMING CONFERENCES
HarrisMartin's Webinar Series: Water Contamination Litigation Presented by EisnerAmper
May 06, 2025